Florida Marketing News
SEE OTHER BRANDS

Fresh news on media and advertising in Florida

Florida Marketing News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Marketing News.

Press releases published on April 28, 2025

Les prix Cpl. Cumming's Watch de MADD Canada honorent les efforts des policiers de l'Alberta pour leur lutte contre la conduite aux capacités affaiblies

Les prix Cpl. Cumming's Watch de MADD Canada honorent les efforts des policiers de l'Alberta pour leur lutte contre la conduite aux capacités affaiblies

EDMONTON, Alberta, 28 avr. 2025 (GLOBE NEWSWIRE) -- Au cours d'une cérémonie qui se tiendra à Edmonton, MADD Canada décernera les prix Cpl. Cumming's Watch à 68 policiers qui se sont surpassés pour retirer les conducteurs aux capacités affaiblies des …

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

Presentations at WHS and SAWC to highlight EscharEx’s mechanism of action, preclinical advantages over SANTYL®, and new data in treating VLUs and DFUs Findings reinforce the ongoing Phase III study in VLUs and support the planned DFU trial strategy YAVNE, …

Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025

Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025

- Preclinical data demonstrates synergy of QTX3544 with EGFR inhibitors, broadly enhancing anti-tumor activity - - Data supports ongoing Phase 1 clinical trial for QTX3544 as monotherapy and in combination with cetuximab in patients with KRASG12V mutations …

Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy  Platform at AACR Annual Meeting

Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy  Platform at AACR Annual Meeting

SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the selection of IL15 …

Global Convention 2025 Empowers Consultants to ‘Go Further’ with Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth

Global Convention 2025 Empowers Consultants to ‘Go Further’ with Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth

SALT LAKE CITY, April 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion …

IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025

IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025

First gamma-delta (γδ) TCE to demonstrate significant γδ T cell expansion and activation, potentially offering an alternative to conventional CD3-based approaches without significant adverse events such as cytokine release syndrome (CRS) INB-600 TCE …

Colabor Announces the Date of Its First Quarter 2025 Results Conference Call

Colabor Announces the Date of Its First Quarter 2025 Results Conference Call

SAINT-BRUNO-DE-MONTARVILLE, Quebec, April 28, 2025 (GLOBE NEWSWIRE) -- Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) will release its results for the first quarter ended March 22, 2025, after market close on Thursday, May 1, 2025. A conference …

Groupe Colabor annonce la date de la tenue de la téléconférence pour ses résultats du premier trimestre 2025

Groupe Colabor annonce la date de la tenue de la téléconférence pour ses résultats du premier trimestre 2025

SAINT-BRUNO-DE-MONTARVILLE, Québec, 28 avr. 2025 (GLOBE NEWSWIRE) -- Groupe Colabor Inc. (TSX : GCL) (« Colabor » ou la « Société ») divulguera ses résultats pour le premier trimestre clos le 22 mars 2025, après la fermeture des marchés, jeudi le 1er mai …

DLH to Announce Fiscal 2025 Second Quarter Financial Results

DLH to Announce Fiscal 2025 Second Quarter Financial Results

ATLANTA, April 28, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to …

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

Marlton, NJ, April 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it reached an important milestone in the INTEGRA-D™ …

CareCloud Launches Healthcare AI Center Set to Become World’s Largest with 500 AI Professionals

CareCloud Launches Healthcare AI Center Set to Become World’s Largest with 500 AI Professionals

SOMERSET, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leading provider of healthcare technology and generative AI solutions, today announced the official launch of its AI Center of Excellence (the “AI CoE”) — a major …

MMA.inc Partners with Brazilian Jiu-Jitsu Icon Clark Gracie: Accelerates BJJLink Expansion and Unlocks Potential New Revenue Streams Across Over 5,700 New Students

MMA.inc Partners with Brazilian Jiu-Jitsu Icon Clark Gracie: Accelerates BJJLink Expansion and Unlocks Potential New Revenue Streams Across Over 5,700 New Students

Key Highlights Clark Gracie renowned Brazilian Jiu-Jitsu champion and grandson of Carlos Gracie, the founder of modern Jiu-Jitsu. Unlocks potential new revenue streams across key U.S. regions and international markets, with Gracie Allegiance affiliates …

ICT Adoption in Aerospace & Defense Set to Accelerate, Projected to Grow at 5.8% CAGR by 2030

ICT Adoption in Aerospace & Defense Set to Accelerate, Projected to Grow at 5.8% CAGR by 2030

Middleton, Massachusetts, April 28, 2025 (GLOBE NEWSWIRE) -- QKS Group, a premier market intelligence and advisory firm, has released its latest vertical-specific research highlighting the growing role of Information and Communication Technology (ICT) in …

XRP ETF US Stock Listing: SAVVY MINING teaches you how to use XRP and DOGE to earn efficient and stable profits every day.

XRP ETF US Stock Listing: SAVVY MINING teaches you how to use XRP and DOGE to earn efficient and stable profits every day.

Washington, D.C., April 28, 2025 (GLOBE NEWSWIRE) -- XRP has taken a historic step! In April, the first 2x leveraged XRP ETF in the United States was officially listed on the NYSE Arca, providing short-term investors with higher income opportunities. As …

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting

New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) FLORHAM PARK, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical …

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug

SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent …

Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium

Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium

MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …

Embecta to host Analyst and Investor Day on May 22, 2025

Embecta to host Analyst and Investor Day on May 22, 2025

PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in …

Nano Dimension to Host 2024 Financial Results and 2025 Outlook Conference Call

Nano Dimension to Host 2024 Financial Results and 2025 Outlook Conference Call

Call to Be Held Wednesday, April 30 at 4:30 PM EST Waltham, Massachusetts, April 28, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today announced it will host …

Exodus Movement, Inc. to Announce First Quarter 2025 Results on May 12, 2025

Exodus Movement, Inc. to Announce First Quarter 2025 Results on May 12, 2025

OMAHA, Neb., April 28, 2025 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it will release its first quarter financial results on Monday, May 12, 2025, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service